Form 10-Q · Quarterly report
American International Group 10-Q, filed Aug 7, 2026
- Filed
- CIK
- 0000005272
- Accession no.
- 0000005272-26-000076
Summary
AIG reported second-quarter 2026 net income attributable to common shareholders of $948 million, or $1.78 per diluted share, down from $1,144 million, or $1.98 per diluted share, a year earlier, on total revenues of $7.09 billion. For the first six months of 2026, net income attributable to AIG common shareholders was $1,711 million, or $3.18 per diluted share, and the company paid $0.50 per common share in quarterly dividends.
Key points
- Second-quarter 2026 total revenues were $7,085 million, little changed from $7,091 million in the second quarter of 2025.
- Second-quarter 2026 premiums were $6,221 million, up from $5,877 million a year earlier, while total net investment income fell to $1,127 million from $1,466 million.
- AIG repurchased $648 million of common stock in the second quarter of 2026, compared with $1,805 million a year earlier.
- Total assets were $163,464 million at June 30, 2026, versus $161,254 million at December 31, 2025.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 41 •Cautionary Note on Forward-Looking Statements 41 •Executive Summary 44 •Critical Accounting Estimates 45 •Consolidated Results of Operations 45 •Business Segment Operations 46 •Use of Non-GAAP Measures 53 •Investments 57 •Insurance Reserves 64 •Liquidity and Capital Resources 67 •Enterprise Risk Management 72 •Glossary 73 •Acronyms 75 ITEM 3 Quantitative and Qualitative Disclosures About Market Risk 75 ITEM 4 Controls and Procedures 75 Part II – Other Information ITEM 1 Legal Proceedings 76 ITEM 1A Risk Factors 76 ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds 76 ITEM 5 Other…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.